Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
46 Cards in this Set
- Front
- Back
Quick Relief of Asthma
|
1. Beta 2 agonists
(pirbuterol, albuterol, levalbuterol) 2. anti-cholinergics (ipratropium) |
|
Side effects of Beta 2 agonists
|
- skeletal muscle tremor
- tachycardia |
|
Long term control of Asthma
|
1. anti-IgE-Ab
2. Long acting Beta 2 agonists 3. theophylline 4. corticosteroids 5. mast cell stabilizers 6. leukotriene modifiers |
|
Long acting Beta 2 agonists
|
- FORMOTEROL
- Salmeterol |
|
corticosteroid for asthma
|
- budesonide
|
|
short term side effects of corticosteroids
|
- cough
- dysphonia - thrush - fluid retention - weight gain - mood alteration |
|
long term side effects of corticosteroids
|
- adrenal axis suppression
- growth suppression - HTN - DM - cataracts - osteoporosis |
|
Mast cell stabilizer for asthma and its side effect
|
- cromolyn
- unpleasant taste |
|
Anti-IgE-Ab
|
- Omalizumab
|
|
Anticholinergic side effects
|
- dry mouth, blurred vision, constipation...etc.
|
|
COPD bronchodilator treatment
|
1. long acting Beta 2 agonist
(formoterol) 2. anti-cholinergic (ipratropium) |
|
Non-nicotinic treatment used for smoking cessation
|
1. Buprion (Zyban)
2. TCAs 3. Lobeline (not available) |
|
Treatment of Stable Angina
|
1. Anti-platelets
2. Beta-blockers 3. CCB 4. Nitrates |
|
1st line treatment in stable angina (in absence of CI)
|
- beta blockers
|
|
2nd line treatment in stable angina
|
- CCB
|
|
1st line treatment for vasospastic angina
|
- CCB
|
|
when does prinzmetals variant angina (vasospastic) occur?
|
- in the morning and at rest
|
|
Nitrates
|
1. NTG
2. isosorbide dinitrate 3. isosorbide mononitrate |
|
MOA of Nitrates
|
- increase cGMP
- increase venodilation - increase arterial dilation (decreasing preload and afterload) |
|
Nitrate - drug interaction
|
- Viagra within last 24 hours
|
|
Beta blockers
a) selective b) non-selective |
a) selective - BBAAM
b) nonselective - the rest - all end in "olol" |
|
Beta blockers - MOA
|
- decrease contractility
- decrease HR - decrease arterial pressure - decrease MVO2 demand |
|
Beta blockers - CI
|
- AV block without pacemaker
- decompensated HF - HR < 50 - systolic BP < 90 - asthma/COPD - PVD - masks sxs of hypoglycemia |
|
Beta-blocker - cardioselectivity
|
- selective BBs have great affinity for beta 1 receptors vs. nonselective (beta 1 and 2)
|
|
CCBs
a) Non-dihydropyridines b) Dihydropyridines |
a) verapamil, diltiazem
b) "dipine" |
|
CCB - MOA
|
- increase O2 supply
- decrease MVO2 demand - decrease contractility - decrease HR - decrease afterload |
|
CCB - CI
|
- AV block without pacemaker
- bradycardia - systolic HF |
|
Antiplatelets
|
1. ASA
2. Clopidogril, Ticlopidine (Thienopyridines) |
|
ASA indications
|
- indicated for all patients with ischemic heart disease without CI
- prevention of UA, MI and death |
|
absolute contraindication in UA/NSTEMI
|
- thrombolytics
|
|
Treatment of UA/NSTEMI
|
1. Anti-platelets
2. Anti-coagulation 3. ACE-Is |
|
Anti-platelet therapy (listed for UA/NSTEMI)
|
1. ASA
2. Clopidogrel 3. Glycoprotein IIb/IIIa receptor blockers |
|
Glycoprotein IIb/IIIa receptor blockers
|
1. Reopro
2. Aggrastat 3. Integrillin |
|
Anti-coagulation Therapy (UA/NSTEMI)
|
1. LMWH (Lovenox) - preferred tx
2. UFH |
|
ACE-Is
|
- "prils"
|
|
atopic dermatitis (eczema)
|
Steroids:
1. Aclovate (cm) 2. Elidel (cm) |
|
vaginal candidiasis
|
1. Fluconazole (Diflucan)
2. Clotrimazole (Gyne-Lotrimin vaginal suppositories) |
|
acne rosacea
|
1. metrogel
2. clindagel |
|
herpetic neuralgia
|
1. Zostrix (capsaicin cream)
2. Elavil tablets (TCA) 3. Neurontin capsules (gabapentin) |
|
Herpes
a) HSV 1 & 2 b) Zoster |
a) Fever sore and Facial:
Abreva, Valtrex (valcyclovir) b) Valtrex, prednisone po, tapered |
|
DOC for obese DM II patients
|
- metformin
|
|
Adverse effects of this DM II oral agent include:
- hypoglycemia - photosensitivity - disulfiram reaction |
- sulfonylurea
|
|
Pramlintide
a) indication b) targets... c) action |
a) adjuvant therapy for DMI & II
b) post prandial hyperglycemia c) improves long-term glycemic and weight control in DM II pts. |
|
Treatment of Lipid Disorders
|
1. HMG-CoA-reductase inhibitors
2. Bile acid resins 3. Niacin 4. Fibric acid derivatives 5. Cholesterol absorption inhibitors |
|
HMG-CoA-reductase inhibitors
|
- "statins"
|
|
HMG-CoA-reductase inhibitors
- MOA |
- inhibit rate limiting step in novo cholesterol biosynthesis
|